{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:43:18Z","timestamp":1791614598126,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00726-019-02700-x","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T11:08:20Z","timestamp":1552388900000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessing acrolein for determination of the severity of brain stroke, dementia, renal failure, and Sj\u00f6gren's syndrome"],"prefix":"10.1007","volume":"52","author":[{"given":"Kazuei","family":"Igarashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01544746","volume":"7","author":"D Ayusawa","year":"1981","unstructured":"Ayusawa D, Iwata K, Seno T (1981) Alteration of ribonucleotide reductase in aphidicolin-resistant mutants of mouse FM3A cells with associated resistance to arabinosyladenine and arabinosylcytosine. Somatic Cell Genet 7:27\u201342","journal-title":"Somatic Cell Genet"},{"key":"2700_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368:387\u2013403","journal-title":"Lancet"},{"key":"2700_CR3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","volume":"48","author":"MA Bradley","year":"2010","unstructured":"Bradley MA, Markesbery WR, Lovell MA (2010) Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 48:1570\u20131576","journal-title":"Free Radic Biol Med"},{"key":"2700_CR4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/tx800465m","volume":"22","author":"J Cai","year":"2009","unstructured":"Cai J, Bhatnagar A, Pierce WM Jr (2009) Protein modification by acrolein: formation and stability of cysteine adducts. Chem Res Toxicol 22:708\u2013716","journal-title":"Chem Res Toxicol"},{"key":"2700_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1471-4159.1999.0720751.x","volume":"72","author":"NY Calingasan","year":"1999","unstructured":"Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer\u2019s disease. J Neurochem 72:751\u2013756","journal-title":"J Neurochem"},{"key":"2700_CR6","first-page":"319","volume-title":"Advances in polyamine research","author":"RA Campbell","year":"1978","unstructured":"Campbell RA, Talwalker YB, Harner MH, Bartos D, Bartos F, Musgrave JE, Puri H, Grettie DP, Dolney AM, Loggan B (1978) Polyamines, uremia, and hemodialysis. Advances in polyamine research, vol 2. Raven Press, New York, pp 319\u2013343"},{"key":"2700_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874467211003020066","volume":"3","author":"TN Dang","year":"2010","unstructured":"Dang TN, Arseneault M, Murthy V, Ramassamy C (2010) Potential role of acrolein in neurodegeneration and in Alzheimer\u2019s disease. Curr Mol Pharmacol 3:66\u201378","journal-title":"Curr Mol Pharmacol"},{"key":"2700_CR8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/01.wnl.0000240127.89601.83","volume":"67","author":"DA Drachman","year":"2006","unstructured":"Drachman DA (2006) Aging of the brain, entropy, and Alzheimer disease. Neurology 67:1340\u20131352","journal-title":"Neurology"},{"key":"2700_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","volume":"38","author":"F Franceschini","year":"2005","unstructured":"Franceschini F, Cavazzana I (2005) Anti-Ro\/SSA and La\/SSB antibodies. Autoimmunity 38:55\u201363","journal-title":"Autoimmunity"},{"key":"2700_CR10","doi-asserted-by":"crossref","first-page":"48658","DOI":"10.1074\/jbc.M309401200","volume":"278","author":"A Furuhata","year":"2003","unstructured":"Furuhata A, Ishii T, Kumazawa S, Yamada T, Nakayama T, Uchida K (2003) N\u03b5-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein. J Biol Chem 278:48658\u201348665","journal-title":"J Biol Chem"},{"key":"2700_CR11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/bjc.1979.100","volume":"39","author":"JM Gaugas","year":"1979","unstructured":"Gaugas JM, Dewey DL (1979) Evidence for serum binding of oxidized spermine and its potent G1-phase inhibition of cell proliferation. Br J Cancer 39:548\u2013557","journal-title":"Br J Cancer"},{"key":"2700_CR12","first-page":"445","volume":"36","author":"S Giovannetti","year":"1969","unstructured":"Giovannetti S, Biagini M, Balestri PL, Navalesi R, Giagnoni P, De Matteis A, Ferro-Milone P, Perfetti C (1969) Uraemia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clin Sci 36:445\u2013452","journal-title":"Clin Sci"},{"key":"2700_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2007.03337.x","volume":"148","author":"V Goeb","year":"2007","unstructured":"Goeb V, Salle V, Duhaut P, Jouen F, Smail A, Ducroix JP, Tron F, Le Loet X, Vittecoq O (2007) Clinical significance of autoantibodies recognizing Sj\u04e7gren\u2019s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary\nSj\u04e7gren\u2019s syndrome. Clin Exp Immunol 148:281\u2013287","journal-title":"Clin Exp Immunol"},{"key":"2700_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","volume":"64","author":"NR Graff-Radford","year":"2007","unstructured":"Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG (2007) Association of low plasma A\u03b242\/A\u03b240 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 64:354\u2013362","journal-title":"Arch Neurol"},{"key":"2700_CR15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0945-053X(98)90116-0","volume":"17","author":"R Hanemaaijer","year":"1998","unstructured":"Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH (1998) A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sj\u04e7gren\u2019s syndrome contain increased latent and active gelatinase-B levels. Matrix Biol 17:657\u2013665","journal-title":"Matrix Biol"},{"key":"2700_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29\u201336","journal-title":"Radiology"},{"key":"2700_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jcp.1040740206","volume":"74","author":"ML Higgins","year":"1969","unstructured":"Higgins ML, Tillman MC, Rupp JP, Leach FR (1969) The effect of polyamines on cell culture cells. J Cell Physiol 74:149\u2013154","journal-title":"J Cell Physiol"},{"key":"2700_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neulet.2005.03.038","volume":"382","author":"Y Hirata","year":"2005","unstructured":"Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, Yamashita F, Asada T, Iwabuchi S, Samejima H (2005) Voxel-based morphometry to discriminate early Alzheimer\u2019s disease from controls. Neurosci Lett 382:269\u2013274","journal-title":"Neurosci Lett"},{"key":"2700_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cca.2015.08.018","volume":"450","author":"T Hirose","year":"2015","unstructured":"Hirose T, Saiki R, Uemura T, Suzuki T, Dohmae N, Ito S, Takahashi H, Ishii I, Toida T, Kashiwagi K, Igarashi K (2015) Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sj\u04e7gren\u2019s syndrome. Clin Chim Acta 450:184\u2013189","journal-title":"Clin Chim Acta"},{"key":"2700_CR20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/mnfr.201100068","volume":"55","author":"K Igarashi","year":"2011","unstructured":"Igarashi K, Kashiwagi K (2011) Protein-conjugated acrolein as a biochemical marker of brain infarction. Mol Nutr Food Res 55:1332\u20131341","journal-title":"Mol Nutr Food Res"},{"key":"2700_CR21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/iub.1363","volume":"67","author":"K Igarashi","year":"2015","unstructured":"Igarashi K, Kashiwagi K (2015) Modulation of protein synthesis by polyamines. IUBMB Life 67:160\u2013169","journal-title":"IUBMB Life"},{"key":"2700_CR22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00726-006-0264-7","volume":"31","author":"K Igarashi","year":"2006","unstructured":"Igarashi K, Ueda S, Yoshida K, Kashiwagi K (2006) Polyamines in renal failure. Amino Acids 31:477\u2013483","journal-title":"Amino Acids"},{"key":"2700_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cca.2015.07.017","volume":"450","author":"K Igarashi","year":"2015","unstructured":"Igarashi K, Yoshida M, Waragai M, Kashiwagi K (2015) Evaluation of dementia by acrolein, amyloid-\u03b2 and creatinine. Clin Chim Acta 450:56\u201363","journal-title":"Clin Chim Acta"},{"key":"2700_CR24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00726-017-2527-x","volume":"50","author":"K Igarashi","year":"2018","unstructured":"Igarashi K, Uemura T, Kashiwagi K (2018) Acrolein toxicity at advanced age: present and future. Amino Acids 50:217\u2013228","journal-title":"Amino Acids"},{"key":"2700_CR25","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.STR.28.10.1932","volume":"28","author":"S Kobayashi","year":"1997","unstructured":"Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S (1997) Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28:1932\u20131939","journal-title":"Stroke"},{"key":"2700_CR26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.53.12.836","volume":"53","author":"YT Konttinen","year":"1994","unstructured":"Konttinen YT, Kangaspunta P, Lindy O, Takagi M, Sorsa T, Segerberg M, Tschesche H, Eisen AZ (1994) Collagenase in Sj\u04e7gren\u2019s syndrome. Ann Rheum Dis 53:836\u2013839","journal-title":"Ann Rheum Dis"},{"key":"2700_CR27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/archneur.60.10.1394","volume":"60","author":"OL Lopez","year":"2003","unstructured":"Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH (2003) Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol 60:1394\u20131399","journal-title":"Arch Neurol"},{"key":"2700_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta PD, Pirttila T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM (2000) Plasma and cerebrospinal fluid levels of amyloid \u03b2 proteins 1\u201340 and 1\u201342 in Alzheimer disease. Arch Neurol 57:100\u2013105","journal-title":"Arch Neurol"},{"key":"2700_CR29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9343(79)91110-0","volume":"66","author":"HM Moutsopoulos","year":"1979","unstructured":"Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL (1979) Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 66:733\u2013736","journal-title":"Am J Med"},{"key":"2700_CR30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0009-8981(65)90171-3","volume":"12","author":"D Muting","year":"1965","unstructured":"Muting D (1965) Studies on the pathogenesis of uremia. Comparative determinations of glucuronic acid, indican, free and bound phenols in the serum, cerebrospinal fluid, and urine of renal diseases with and without uremia. Clin Chim Acta 12:551\u2013554","journal-title":"Clin Chim Acta"},{"key":"2700_CR31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbrc.2012.12.057","volume":"430","author":"M Nakamura","year":"2013","unstructured":"Nakamura M, Tomitori H, Suzuki T, Sakamoto A, Terui Y, Saiki R, Dohmae N, Igarashi K, Kashiwagi K (2013) Inactivation of GAPDH as one mechanism of acrolein toxicity. Biochem Biophys Res Commun 430:1265\u20131271","journal-title":"Biochem Biophys Res Commun"},{"key":"2700_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2015.11.012","volume":"244","author":"M Nakamura","year":"2016","unstructured":"Nakamura M, Uemura T, Saiki R, Sakamoto A, Park H, Nishimura K, Terui Y, Toida T, Kashiwagi K, Igarashi K (2016) Toxic acrolein production due to Ca2+ influx by the NMDA receptor during stroke. Atherosclerosis 244:131\u2013137","journal-title":"Atherosclerosis"},{"key":"2700_CR33","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/clinchem\/34.11.2264","volume":"34","author":"T Niwa","year":"1988","unstructured":"Niwa T, Takeda N, Tatematsu A, Maeda K (1988) Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 34:2264\u20132267","journal-title":"Clin Chem"},{"key":"2700_CR34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","volume":"6","author":"A Nordberg","year":"2010","unstructured":"Nordberg A, Rinne JO, Kadir A, Langstrom B (2010) The use of PET in Alzheimer disease. Nat Rev Neurol 6:78\u201387","journal-title":"Nat Rev Neurol"},{"key":"2700_CR35","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1021\/tx400316s","volume":"26","author":"AE Pegg","year":"2013","unstructured":"Pegg AE (2013) Toxicity of polyamines and their metabolic products. Chem Res Toxicol 26:1782\u20131800","journal-title":"Chem Res Toxicol"},{"key":"2700_CR36","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/1529-0131(200012)43:12<2807::AID-ANR22>3.0.CO;2-M","volume":"43","author":"P Perez","year":"2000","unstructured":"Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, Pinto R, Romo R, Martinez B, Gonzalez MJ (2000) Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sj\u04e7gren\u2019s syndrome. Arthr Rheum 43:2807\u20132817","journal-title":"Arthr Rheum"},{"key":"2700_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-006-9022-6","volume":"26","author":"M Ram","year":"2006","unstructured":"Ram M, Sherer Y, Shoenfeld Y (2006) Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 26:299\u2013307","journal-title":"J Clin Immunol"},{"key":"2700_CR38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neurobiolaging.2010.04.029","volume":"31","author":"SL Risacher","year":"2010","unstructured":"Risacher SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR Jr, Weiner MW, Saykin AJ, Alzheimer\u2019s Disease Neuroimaging I (2010) Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 31:1401\u20131418","journal-title":"Neurobiol Aging"},{"key":"2700_CR39","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbrc.2010.12.107","volume":"404","author":"R Saiki","year":"2011","unstructured":"Saiki R, Park H, Ishii I, Yoshida M, Nishimura K, Toida T, Tatsukawa H, Kojima S, Ikeguchi Y, Pegg AE, Kashiwagi K, Igarashi K (2011) Brain infarction correlates more closely with acrolein than with reactive oxygen species. Biochem Biophys Res Commun 404:1044\u20131049","journal-title":"Biochem Biophys Res Commun"},{"key":"2700_CR40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.12336","volume":"127","author":"R Saiki","year":"2013","unstructured":"Saiki R, Hayashi D, Ikuo Y, Nishimura K, Ishii I, Kobayashi K, Chiba K, Toida T, Kashiwagi K, Igarashi K (2013) Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells. J Neurochem 127:652\u2013659","journal-title":"J Neurochem"},{"key":"2700_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0006-291X(03)00716-2","volume":"305","author":"K Sakata","year":"2003","unstructured":"Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N, Igarashi K (2003) Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 305:143\u2013149","journal-title":"Biochem Biophys Res Commun"},{"key":"2700_CR42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2010-100405","volume":"21","author":"M Singh","year":"2010","unstructured":"Singh M, Dang TN, Arseneault M, Ramassamy C (2010) Role of by-products of lipid oxidation in Alzheimer\u2019s disease brain: a focus on acrolein. J Alzheimer\u2019s Dis 21:741\u2013756","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2700_CR43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.lfs.2007.09.011","volume":"81","author":"Y Tanaka","year":"2007","unstructured":"Tanaka Y, Marumo T, Omura T, Yoshida S (2007) Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models. Life Sci 81:1381\u20131388","journal-title":"Life Sci"},{"key":"2700_CR44","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1161\/01.STR.0000190004.36793.2d","volume":"36","author":"H Tomitori","year":"2005","unstructured":"Tomitori H, Usui T, Saeki N, Ueda S, Kase H, Nishimura K, Kashiwagi K, Igarashi K (2005) Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 36:2609\u20132613","journal-title":"Stroke"},{"key":"2700_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1050-1738(99)00016-X","volume":"9","author":"K Uchida","year":"1999","unstructured":"Uchida K (1999) Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9:109\u2013113","journal-title":"Trends Cardiovasc Med"},{"key":"2700_CR46","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1073\/pnas.95.9.4882","volume":"95","author":"K Uchida","year":"1998","unstructured":"Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95:4882\u20134887","journal-title":"Proc Natl Acad Sci USA"},{"key":"2700_CR47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbrc.2016.03.137","volume":"473","author":"T Uemura","year":"2016","unstructured":"Uemura T, Watanabe K, Ishibashi M, Saiki R, Kuni K, Nishimura K, Toida T, Kashiwagi K, Igarashi K (2016) Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging. Biochem Biophys Res Commun 473:630\u2013635","journal-title":"Biochem Biophys Res Commun"},{"key":"2700_CR48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biocel.2017.05.004","volume":"88","author":"T Uemura","year":"2017","unstructured":"Uemura T, Suzuki T, Saiki R, Dohmae N, Ito S, Takahashi H, Toida T, Kashiwagi K, Igarashi K (2017) Activation of MMP-9 activity by acrolein in saliva from patients with primary Sj\u04e7gren\u2019s syndrome and its mechanism. Int J Biochem Cell Biol 88:84\u201391","journal-title":"Int J Biochem Cell Biol"},{"key":"2700_CR49","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/STROKEAHA.118.021755","volume":"49","author":"T Uemura","year":"2018","unstructured":"Uemura T, Watanabe K, Ko K, Higashi K, Kogure N, Kitajima M, Takayama H, Takao K, Sugita Y, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K (2018) Protective effects of brain infarction by N-acetylcysteine derivatives. Stroke 49:1727\u20131733","journal-title":"Stroke"},{"key":"2700_CR50","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.STR.0000068408.82115.D2","volume":"34","author":"SE Vermeer","year":"2003","unstructured":"Vermeer SE, Hollander M, van Dijk EJ, Hofman A,\nKoudstaal PJ, Breteler MM, Rotterdam Scan S (2003) Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34:1126\u20131129","journal-title":"Stroke"},{"key":"2700_CR51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","volume":"6","author":"SE Vermeer","year":"2007","unstructured":"Vermeer SE, Longstreth WT Jr, Koudstaal PJ (2007) Silent brain infarcts: a systematic review. Lancet Neurol 6:611\u2013619","journal-title":"Lancet Neurol"},{"key":"2700_CR52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-2012-120253","volume":"32","author":"M Waragai","year":"2012","unstructured":"Waragai M, Yoshida M, Mizoi M, Saiki R, Kashiwagi K, Takagi K, Arai H, Tashiro J, Hashimoto M, Iwai N, Uemura K, Igarashi K (2012) Increased protein-conjugated acrolein and amyloid-\u03b240\/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis 32:33\u201341","journal-title":"J Alzheimers Dis"},{"key":"2700_CR53","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bbrc.2009.12.049","volume":"391","author":"M Yoshida","year":"2010","unstructured":"Yoshida M, Higashi K, Jin L, Machi Y, Suzuki T, Masuda A, Dohmae N, Suganami A, Tamura Y, Nishimura K, Toida T, Tomitori H, Kashiwagi K, Igarashi K (2010a) Identification of acrolein-conjugated protein in plasma of patients with brain infarction. Biochem Biophys Res Commun 391:1234\u20131239","journal-title":"Biochem Biophys Res Commun"},{"key":"2700_CR54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2010.03.031","volume":"211","author":"M Yoshida","year":"2010","unstructured":"Yoshida M, Higashi K, Kobayashi E, Saeki N, Wakui K, Kusaka T, Takizawa H, Kashiwado K, Suzuki N, Fukuda K, Nakamura T, Watanabe S, Tada K, Machi Y, Mizoi M, Toida T, Kanzaki T, Tomitori H, Kashiwagi K, Igarashi K (2010b) Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 211:475\u2013479","journal-title":"Atherosclerosis"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-019-02700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-019-02700-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-019-02700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:20:57Z","timestamp":1583871657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-019-02700-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1007\/s00726-019-02700-x","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors decrare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants and animals were in accordance with the ethical standards of the ethics committee of Chiba University and with the 1964 Helsinki declaration and the later amendments or comparable ethics standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}